Hikma Pharmaceuticals USA Inc. recalls Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE Gm

Recalled January 4, 2023 · FDA recall D-0090-2023 · Hikma Pharmaceuticals USA

Hazard

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg. · FDA Class II

Units

13,760 vials

Sold at

USA Nationwide

Description

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

Product

Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH, Germany, Distributed by Hikma Berkeley Heights, NJ 07922, NDC 0143-9299-01

Manufacturer(s)

Hikma Pharmaceuticals USA Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →